跳至主要内容
临床试验/IRCT20231025059850N1
IRCT20231025059850N1招募中3 期

Comparing the efficacy and safety of oral finasteride with oral dutasteride in moderate to severe male androgenetic alopecia

Esfahan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
Male

入选标准

  • Male patients diagnosed with moderate to severe androgenetic alopecia (grade 3, 4, 5 Hamilton-norwood scale)
  • Do not have any of the followings (Non-inclusion criteria): any serious systemic disease, psoriasis or lichen planus; other types of alopecia (including anagen effluvium, telogen effluvium and scarring alopecia); any andrological condition known to affect semen parameters and male fertility (including varicocele, cryptorchidism, testicular cancer, testicular trauma, orchitis, urinary tract infection; previous chemotherapy or radiotherapy); history of hair transplant; history of breast cancer or male infertility in first degree relatives.
  • Patients who have not received any treatment for alopecia in the past three months

排除标准

  • Serum levels of prostate specific antigen (PSA) greater than 2 ng/ml
  • Abnormal liver function tests (except chronic stable hepatitis B and C)

研究者

相似试验